Increasing successful clinical chemical pregnancy using growth hormone medication in women who are candidates for IVF. Complications of attempted introduction of fertilized ovum following in vitro fertilization
Conditions
Interventions
Intervention 1: Intervention group: In the growth hormone intervention group (Cinatropin-cinagen), 4 international units per day are administered subcutaneously once a day simultaneously with the star
Sponsors
Hamedan University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 40 Years
Inclusion criteria
Inclusion criteria: Infertile women aged 18-40 and candidates for IVF with one failed transfer Having 2-3 frozen embryos of good quality grade A and B BMI<30
Exclusion criteria
Exclusion criteria: Underlying disease such as diabetes, hypothyroidism, etc PCOS And severe endometriosis.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pregnancy outcome success rate in women candidates for frozen embryo transfer with a history of one failed transfer using growth hormone medication. Timepoint: A maternal blood sample will be taken 12-16 days after intrauterine insemination to check for beta HCG to check for pregnancy. Finally, pregnancy is confirmed based on clinical level measurements by the presence of a gestational sac on sonography at the fourth week. Pregnancy and success rates of intrauterine insemination in both groups are then compared. Method of measurement: Chemical pregnancy assessment with beta HCG check on days 12-16 after intervention and clinical pregnancy measurement by the presence of gestational sac on sonography at 4th week. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSHamim Pilehvari
Hamedan University of Medical Sciences
Outcome results
None listed